Metastatic Triple-Negative Breast Carcinoma trials recruiting in Ohio
Fewer than 3 recruiting trials found.
All Metastatic Triple-Negative Breast Carcinoma trials nationally
2
Recruiting in Ohio
1
Cities with sites
Cities in Ohio
Columbus 2
Recruiting trials in Ohio
- Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
- Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer